Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Darusentan> ?p ?o. }
Showing items 1 to 63 of
63
with 100 items per page.
- Darusentan abstract "Darusentan (LU-135252; HMR-4005) is an endothelin receptor antagonist. Gilead Colorado, a subsidiary of Gilead Sciences, under license from Abbott Laboratories, is developing darusentan for the potential treatment of uncontrolled hypertension.In June 2003, Myogen licensed the compound from Abbott for its application in the cancer field.In May 2007, a randomized, double-blind, active control, parallel assignment, safety and efficacy phase III trial was initiated in subjects who had completed the maintenance period of the DAR-312 study.".
- Darusentan atcPrefix "none".
- Darusentan casNumber "171714-84-4".
- Darusentan fdaUniiCode "33JD57L6RW".
- Darusentan iupacName "(2S)-2-(4,6-Dimethoxypyrimidin-2-yl)oxy-3-methoxy-3,3-di(phenyl)propanoic acid".
- Darusentan pubchem "177236".
- Darusentan thumbnail Darusentan.png?width=300.
- Darusentan wikiPageID "21714783".
- Darusentan wikiPageRevisionID "541790564".
- Darusentan atcPrefix "none".
- Darusentan c "22".
- Darusentan casNumber "171714".
- Darusentan chembl "23261".
- Darusentan chemspiderid "154336".
- Darusentan eliminationHalfLife "45000.0".
- Darusentan h "22".
- Darusentan hasPhotoCollection Darusentan.
- Darusentan inchi "1".
- Darusentan inchikey "FEJVSJIALLTFRP-LJQANCHMBS".
- Darusentan iupacName "-2".
- Darusentan metabolism Liver.
- Darusentan molecularWeight "410.42".
- Darusentan n "2".
- Darusentan o "6".
- Darusentan pubchem "177236".
- Darusentan routesOfAdministration "Oral".
- Darusentan smiles "COC1=CCOC".
- Darusentan stdinchi "1".
- Darusentan stdinchikey "FEJVSJIALLTFRP-LJQANCHMSA-N".
- Darusentan unii "33".
- Darusentan verifiedfields "changed".
- Darusentan verifiedrevid "384091933".
- Darusentan watchedfields "changed".
- Darusentan subject Category:Endothelin_receptor_antagonists.
- Darusentan subject Category:Phenol_ethers.
- Darusentan subject Category:Pyrimidines.
- Darusentan type Abstraction100002137.
- Darusentan type Base114618253.
- Darusentan type Chemical114806838.
- Darusentan type Compound114818238.
- Darusentan type Element114840755.
- Darusentan type Material114580897.
- Darusentan type Matter100020827.
- Darusentan type Part113809207.
- Darusentan type PhenolEthers.
- Darusentan type PhysicalEntity100001930.
- Darusentan type Pyrimidine114999913.
- Darusentan type Pyrimidines.
- Darusentan type Quintessence114847103.
- Darusentan type Relation100031921.
- Darusentan type Substance100019613.
- Darusentan type Drug.
- Darusentan type DrugProduct.
- Darusentan type FunctionalSubstance.
- Darusentan comment "Darusentan (LU-135252; HMR-4005) is an endothelin receptor antagonist.".
- Darusentan label "Darusentan".
- Darusentan sameAs m.05mqkl4.
- Darusentan sameAs Q5225810.
- Darusentan sameAs Q5225810.
- Darusentan sameAs Darusentan.
- Darusentan wasDerivedFrom Darusentan?oldid=541790564.
- Darusentan depiction Darusentan.png.
- Darusentan isPrimaryTopicOf Darusentan.